Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: i-node who wrote (208924)	8/18/2021 12:06:23 PM
From: Sam	2 Recommendations Recommended By bentway Terry Maloney Read Replies (1) \| Respond to of 363134

Funny, back in June you were touting a study that claimed great success with HCQ when using it with ventilated patients--that is the problem with telling so many lies, you can't keep them straight. from Message 33354975 Was Trump right about hydroxychloroquine all along? New study shows drug touted by former president can increase COVID survival rates by 200%A study on 255 patients was done by St Barnabas Medical Center in New JerseyThe resulting report, out May 31, found hydroxychloroquine to be effectiveThe drug, when used in a high dose and with zinc, increased survival ratesThe authors found it was only helpful in severe cases of COVID-19Patients given the drug as part of the trial were on ventilators Trump's allies have seized on the report to declare that he was correctAs president, Trump touted hydroxychloroquine as a preventative treatmentHe even took it himself, despite doctors then warning it could be dangerous A growing number of studies are now suggesting the drug could be useful Hydroxychloroquine with zinc could increase COVID-19 survival rates by as much as nearly 200% \| Daily Mail Online key points excerpted from the above article: A study on 255 patients was done by St Barnabas Medical Center in New Jersey The resulting report, out May 31, found hydroxychloroquine to be effective The drug, when used in a high dose and with zinc, increased survival rates The authors found it was only helpful in severe cases of COVID-19 Patients given the drug as part of the trial were on ventilators